Helping Children Receive an Earlier Autism Diagnosis

Earlier Diagnosis + Earlier Intervention = Better Outcomes

A NEW DIAGNOSTIC TOOL

Our NPDX ASD test may lead to an earlier diagnosis for children with autism spectrum disorder (ASD).

Earlier access to specialty care and treatments improve outcomes

Posters & Publications

NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.

Amino Acid Dysregulation Metabotypes Diagnostics for Autism Spectrum Disorders – INSAR 2018 [PDF]

Presented at the International Society for Autism Research (INSAR) Annual Meeting in Rotterdam, Netherlands; May 2018. NeuroPointDX’s autism clinical study, Children’s Autism Metabolome Project (CAMP), is the largest study to identify changes in metabolism associated with autism spectrum disorder (ASD). Over 1,100 children enrolled in the study at eight clinical sites across the United States.[…]

NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.

Amino Acid Dysregulation Metabotypes [Biological Psychiatry, 2018]

Amino acid dysregulation metabotypes: potential biomarkers for diagnosis and individualized treatment for subtypes of autism spectrum disorder ASD is currently diagnosed based on behavioral characteristics exhibited by an affected child. While specialist clinicians are able to confidently diagnose children as young as 24 months, the average age of diagnosis in the United States is over[…]

NEWS

NeuroPointDX to Present Precision Medicine Approaches to Diagnosing and Treating Autism at National TACA Autism Conference

Company Will Present New Data from the 1,100 Patient Clinical Study, the Children’s Autism Metabolome Project (CAMP) MADISON, Wis.–(BUSINESS WIRE)–NeuroPointDX, a busines unit of Stemina Biomarker Discovery, today announced the company will present recent data from the Children’s Autism Metabolome Project (CAMP), its large, comprehensive clinical study, supporting its precision medicine approach to the diagnosis[…]

How can I get the NPDX ASD test now?

You can find more information in our FAQs.

Read our paper, published in Biology Psychiatry, which details the results of our clinical study.